Literature DB >> 23286290

Cardiac consequences of anti-inflammatory drugs in experimental models.

Nolwenn Merlet1, David Busseuil, Éric Rhéaume, Jean-Claude Tardif.   

Abstract

Although heart failure is predominantly caused by cardiovascular conditions such as hypertension, coronary heart disease and valvular heart disease, it can also be caused by adverse drug reactions. Several medications have been shown to have cardiotoxic effects. Among those therapeutic agents, anti-inflammatory drugs, including exogenous glucocorticoids, nonsteroidal anti-inflammatory drugs and biologics, which are used to treat a broad range of diseases that are associated with inflammatory processes, are widely prescribed in clinical practice. In this review, we discuss insights from experimental models on the beneficial and cardiotoxic effects of anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23286290     DOI: 10.2174/1871523011312010005

Source DB:  PubMed          Journal:  Antiinflamm Antiallergy Agents Med Chem        ISSN: 1871-5230


  3 in total

Review 1.  Glucocorticoid signaling in the heart: A cardiomyocyte perspective.

Authors:  Robert H Oakley; John A Cidlowski
Journal:  J Steroid Biochem Mol Biol       Date:  2015-03-21       Impact factor: 4.292

2.  N'-[(E)-Benzyl-idene]-2-(6-meth-oxy-naphthalen-2-yl)propano-hydrazide.

Authors:  Joel T Mague; Mehmet Akkurt; Shaaban K Mohamed; Mahmoud A A El-Remaily; Mustafa R Albayati
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-05

3.  N'-[(E)-2-Chloro-benzyl-idene]-2-(6-meth-oxy-naphthalen-2-yl)propano-hydrazide.

Authors:  Joel T Mague; Shaaban K Mohamed; Mehmet Akkurt; Herman Potgieter; Mustafa R Albayati
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.